Spotlight – What's next in Nash
The next few months will see some important mid-stage Nash results, from Viking, 89Bio, Northsea and others.
Intercept’s big Nash day draws near
Intercept Pharmaceuticals and the whole Nash field await Ocaliva’s pivotal readout.